Target intelligence / Profile preview

Enhancer and Promoter Regulatory Elements

Molecular classification
Other, Cis-regulatory element, Non-coding genomic element
01

Overview

Enhancer and promoter elements are short cis-regulatory DNA sequences essential for the initiation and control of gene transcription in eukaryotes. Promoters typically reside near the transcription start site and recruit the basal transcriptional machinery, while enhancers can be distant and facilitate transcription by looping into proximity with their target promoter and recruiting transcription factors and coactivator complexes. These elements are marked by distinct chromatin modifications (promoters by H3K4me3, enhancers by H3K4me1 and H3K27ac), interact with specific proteins, and their disruption can lead to misregulation of genes, with established roles in developmental and disease processes including cancer and neurological disorders. "Enhancer_promoter" (ENSG00000291338) refers to gene regulatory cis-elements, not a conventional therapeutic target; this identifier does not correspond to a protein, receptor, or drug-targetable entity. The entry is best understood as a generic label for genomic regions critical for transcriptional regulation but is factually and functionally incorrect for use as a canonical molecular target.

Other names
enhancerpromotercis-regulatory elementregulatory sequencegene regulatory element
02

Mechanism of action

Not applicable directly to a canonical drug target; epigenetic drugs and genome-editing agents (CRISPR/Cas9) can modulate enhancer/promoter function indirectly.

03

Biological functions

Regulation of gene transcriptionChromatin remodeling and accessibilityCell fate and differentiation controlSignal integration via transcriptional activators and repressorsEstablishing spatiotemporal gene expression patterns
04

Disease associations

Cancer (mutations/disruptions can misregulate oncogenes)Neurodevelopmental disease (aberrant enhancer-promoter interactions)Other (potential roles in many diseases driven by gene regulation errors)
05

Safety considerations

Not applicable as a direct therapeutic targetGenome-wide editing of enhancer or promoter regions carries risk of off-target effects and broad transcriptional misregulation
06

Interacting drugs

Epigenetic modulators (e.g. HDAC inhibitors) (indirectly influence activity)

1 more in the full profile.

07

Biomarkers

Enhancer RNA (eRNA) expression (may indicate active enhancers in cell-type specific contexts)Chromatin marks (e.g., H3K27ac, H3K4me1) indicative of active enhancer and promoter states

Beyond the preview

Go deeper on Enhancer and Promoter Regulatory Elements.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enhancer and Promoter Regulatory Elements.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call